HBV infection alters the immune microenvironment at the tumor margins in HCC patients, increasing PD‐1+CD8+ TRM cells with impaired function, which exacerbates HBV‐related liver damage and fibrosis. The gene discussed is CD8A; the disease is hepatocellular carcinoma.